DERBI Foundation’s Post

On Day-2 of India Global Innovation Connect 2024, Sri. Darshan H V, IAS, Managing Director of KITS and Director of the Dept of Electronics, IT, Bt, S&T, Government of Karnataka, participated in a panel discussion on "Biotech and Genomics: Navigating Turbulences and Seizing Opportunities." During the session, the following points were highlighted. - The biotech industry is undergoing transformative changes, positioning India as a leader in global pharmaceutical innovation. - India's biotech and life sciences sector is emerging as a critical hub, driving significant advancements in drug development and healthcare solutions. - The Genome India Project's successful sequencing of 10,000 Indian genomes provides a vital database, enhancing our understanding of genetic diversity and fostering personalized medicine. - The sector is at a pivotal moment, with technological advancements and evolving market dynamics creating unprecedented opportunities for growth and innovation. - Companies must adapt to increasingly stringent funding environments, seeking sustainable financial strategies. - Startups can harness AI, CRISPR technology, and vast data resources to accelerate research and development, driving efficiency and innovation. - Strengthening partnerships between biotech/genomics startups and pharmaceutical companies is essential for translating scientific discoveries into market-ready products. - Navigating the intricate regulatory and ethical landscape is crucial as the sector advances, ensuring compliance and fostering public trust. - Government policies, such as those in Karnataka, are designed to support the growth of the biotech and genomics industry by simplifying regulatory processes, offering fiscal incentives, and fostering public-private partnerships. #IGIC2024 #BiotechInnovation #Genomics #PharmaceuticalInnovation #GenomeIndiaProject #BiotechStartups #AIinBiotech #CRISPR #GeneticDiversity #TechAdvancements #BiotechFunding #BiotechCollaboration #RegulatoryCompliance #EthicalBiotech #IndiaBiotech #TechLeadership #GovernmentSupport Leela Maitreyi | Bugworks Research Inc. | Vivek Mishra | Fibroheal Woundcare Pvt Ltd | Utpal Tatu | Equine Biotech Pvt. Ltd. | Indian Institute of Science (IISc) | VIVEKANAND TIWARI | ClimateCrop Ltd. | Ken Woosuk Choi | 조선일보 (The Chosunilbo) Tata Digital Private Limited | Axilor Ventures | WIZ Freight | Covington & Burling LLP | Swissnex in India, Consulate General of Switzerland | Business France | JETRO | La French Tech India | Start2 Group | Smadja & Smadja 

"Good Partners Don't Just Back You - They Drive You to Think Bigger and Aim Higher." ~ Team Theraxcel Healthcare We would like to take a moment to sincerely thank Centre for Cellular and Molecular Platforms (C-CAMP), National Centre for Biological Sciences (NCBS) for their unwavering support throughout our journey. Their guidance and resources have been pivotal in helping us navigate the challenges of building and scaling our startup. From offering technical expertise to providing the mentorship we needed to refine our innovations, #CCAMP has played a critical role in shaping our growth and success. Meeting the #CCAMP team again at Global Bio India - 2024 was not just a moment of reflection, but also a reminder of the importance of strong partnerships. They believed in our vision from the early days and have been with us every step of the way. Their support has empowered us to explore new ideas, expand our capabilities, and take bold steps toward realizing our mission. We are truly grateful for their role in advancing our startup and look forward to continuing this journey together, reaching even greater milestones in the biotech space. Yenepoya Technology Incubator Yenepoya University Biotechnology Industry Research Assistance Council (BIRAC) DBT BIRAC Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem) Abhijna Ballal Anne Boyina Sravani Vivek Ghate Nitya Raman Karthik Mahesh, Ph.D. Ravi Nayar Neelanjana Janardan Dr. Saumya Prasad Taslimarif Saiyed, PhD #Partnerships #Innovation #Growth #Collaboration #Startup #Success #Teamwork #Support #Biotech #Healthcare #Scaling #Future #Technology #Community #InnovationHub #Networking #Research #Mentorship #Incubation #Ecosystem

Meet three #healthtech Swiss startups at BioAsia 2024 in a few days! BioAsia — held in Hyderabad, India, from 26 to 28 February — is the 21st edition of the premier life sciences and healthcare forum in Asia! Dr. Thomas Lumpe from breathe medical Dr. Myriam Merarchi from BEYOND GENOMiX and Dr. Carin Lightner from ENANTIOS will be at BioAsia. These medtech startups are supported by Innosuisse, the Swiss innovation agency. They will also be visiting Bengaluru between 23 February and 2 March. The products of these startups range from medical devices and drug discovery instrumentation to diagnostic kits. The Swiss #sciencepreneurs will be exploring India’s massive healthtech market to seek collaboration, and understand India as a #manufacturing hub and/or as a potential #market. If you are interested in forging new Indo-Swiss collaborations, connect with our Senior Programme Manager, Aparna Kumaraswamy (aparna.kumaraswamy@swissnex.org). Follow us for more updates on BioAsia! For more information, visit our website: https://lnkd.in/g8UkM5NZ The BioAsia 2024 website: https://bioasia.in/2024/ Swetha Suresh, PhD; Deepika Prithviraj, Adrien Mérillat Swissnex, Swiss Business Hub India #swissstartups #startups #medtech #biotech #science #technology #events #healthcare #innovation #entrepreneurs #lifesciences #data #artificialintelligence #medicaldevices #drugdiscovery #diagnostics #therapeutics

Life sciences GCC roundtable by EY featured fireside chat between GM Bt Parnika Pavanram and Arindam Sen, Partner, EY India on 5th September. Conversation revolved around Karnataka's impressive 41% bioeconomy growth over two years. The discussion highlighted key drivers behind this surge, including government initiatives like KITS, world-class R&D institutions such as IISc and NCBS, and a robust startup ecosystem supported by incubators like BBC. Talent development emerged as a crucial focus, with programs like Biotech Finishing Schools and BiSEP addressing the industry's need for skilled professionals. The chat also explored how this growth impacts economic diversification, healthcare innovation, and global competitiveness. With major players like Immuneel, Biocon, and AstraZeneca driving innovation, Karnataka is solidifying its position as a leading biotech hub, fostering sustainable growth and attracting global partnerships in the life sciences sector. Priyank M Kharge | Dr. Ekroop Caur | Ruchi Bindal | Parnika Pavanram | Arindam Sen | Vijay Shankar | Sonam Mahajan | Ekant Tyagi | Prathiba K P 

Navigating Future of #LifeSciences Clusters in India In the dynamic landscape of global healthcare, India emerges as a promising frontier for life sciences clusters, offering a unique blend of challenges and opportunities. Globally, it is recognised within the top 12 biotechnology destinations and ranks third in the Asia-Pacific region. At the cusp of 2024, stakeholders must understand the intricacies of this sector as well as its potential to not only revolutionise healthcare but also stimulate economic growth. Vishal Goel, Managing Director, Rx Propellant digs deeper into this.

📅 Next month, at the 2024 Life Sciences Summit, sector leaders from across the UK will unite in Aberdeen. 🤝 The summit, co-created and delivered by The Times and Opportunity North East Limited, will explore how one of the UK's most dynamic industries is tackling global health challenges through scientific creativity, commercial innovation and technological advancement and improving lives while delivering robust economic growth. 📈 It will also provide a unique forum to showcase north east Scotland's distinctive life sciences sector, innovation-led biotechs, entrepreneurial ecosystem and ambition to be at the heart of the future economy. 📍 At King's College Conference Centre at the University of Aberdeen on 20 March 2024, the summit will share commercial and entrepreneurial perspectives on this dynamic, innovative and fast-growing sector. 👩🔬 👨🔬 Ahead of the summit, some of the 30+ expert speakers on the agenda - Indro Mukerjee, CEO, Innovate UK; Clare Terlouw, Head of LifeArc Ventures; Dr Poonam Malik, MBA, FRSE FRSB, Chair, Microplate Dx Limited; Martin Turner, Associate Director Policy, Public Affairs and Investor Relations, BioIndustry Association (BIA), and Deborah O'Neil, CEO, NovaBiotics Ltd and chair of ONE Life Sciences and #ONEBioHub - provide a flavour of what to expect on the day and explain why the summit will offer insights and connections for innovative biotech, medtech and healthtech businesses to scale and grow. 🎞 Watch the video below 👇 ℹ To learn more about the summit and purchase your ticket, please follow the link from the QR code at the beginning of the video or follow the link in the comments below. #OpportunityNorthEast #lifesciences #Aberdeen News Live

Exploring the UAE’s Healthcare and Biotech Innovations: Fresh Insights and New Friends My first trip to the UAE turned into a full month of great experiences! It all started with the HealthTech Leaders Summit organized by Forbes Middle East, followed by GITEX GLOBAL Largest Tech & Startup Show in the World — and suddenly, I was moving from one great event to the next. What began as a simple idea to learn more about the local healthcare and biotech ecosystem quickly turned into a deep dive into the region's innovations. I was fortunate to meet brilliant people from organizations like the Department of Health Abu Dhabi, Dubai Health Authority, Dubai Science Park, Hub71, Ministry of Health and Prevention - UAE, Mohammed Bin Rashid Innovation Fund, Sharjah Entrepreneurship Center (Sheraa), Sharjah Research, Technology and Innovation Park (SRTI Park), Shorooq Partners, PureHealth, Technology Innovation Institute, and Abu Dhabi Investment Authority (ADIA). Thanks to their hospitality, I gained valuable insights into local healthcare transformation, the ecosystem, and potential opportunities. Adam and I will summarize everything in an upcoming piece, but here’s a quick takeaway: ➡ The healthcare structure here is quite interesting, with standout achievements that could serve as valuable case studies. ➡ There are also challenges, many of which are similar to those in EU healthcare. ➡ Some of the amazing programs include one of the top genomic sequencing initiatives in the region, and projects that analyze genomic, environmental, epigenetic, and health data for breakthrough insights. ➡ These efforts are driving advancements in areas like drug discovery, bioinformatics, AI, and clinical genomics — all part of the broader Life Sciences Platform led by M42 Health, Microsoft, and other ecosystem partners. ➡ Not to mention PureHealth’s second phase of their regional longevity trial, which explores how specific activities and interventions impact health and longevity. None of this would’ve been possible without my amazing friend Alla, who hosted me during my stay. She’s building her own executive search and staffing company in the region, and I couldn’t be more grateful to the Global Shapers Community for such people. I’m happy to have made new friends in the UAE, and now this city feels like home too. Now, I’m in Riyadh and excited to see everyone at the Global Health Exhibition - ملتقى الصحة العالمي over the next three days! #healthtech #biotech #lifesciences #GITEX #globalshapers #GHE2024 #healthcaretransformation #digitalhealth #WEF

🌟 Upcoming Panel at SpinOff 2024: "INNAXE: Navigating the European Spin-off Ecosystem" 🌟 Join us for a dynamic discussion exploring the complex landscape of European spin-offs in the Life Sciences and Healthtech sectors. This panel brings together distinguished leaders who are at the forefront of innovation in their respective regions. Event Details: Date: June 21st, 2024 Time: 12:00 - 12:45 Location: Main Stage, SpinOff 2024 Panelists Include: Montse Daban Marín, PhD: As President of the Board at the Council of European BioRegions and Director at BioCat, Montse leverages her vast experience in strategic foresight and international relations to drive forward the bioregion’s agenda, promoting innovative health solutions across Europe. Hickmah Tagaully: Heading European Affairs at Medicen Paris Region, Hickmah focuses on linking biotech and medtech ecosystems across Europe, enhancing collaborative innovations that address complex health challenges. Kristina Eskenazi: Chair of the Health & Life Sciences Cluster, Kristina is instrumental in orchestrating initiatives that propel the Bulgarian life sciences sector onto the global stage, emphasizing sustainable health solutions. Karen Lindegaard: As an International Programme Manager at the Danish Life Science Cluster, Karen facilitates international cooperation, helping Danish life sciences enterprises expand their global footprint through strategic partnerships. Friedemann Loos: Representing the BioRN Life Science Cluster Rhine-Neckar, Friedemann drives the cluster’s efforts in fostering cutting-edge biotechnological research and development, making significant impacts on regional and international biotech landscapes. Alberto Baldi: As a Senior Project Manager at CEBR, Alberto is deeply involved in strengthening Europe's bioregional networks, focusing on enhancing the innovation capacity of clusters through strategic collaborations and knowledge exchange. About INNAXE: INNAXE (Inclusive and Aligned Innovation Agendas Across Europe) is a groundbreaking project led by BioCat under the Horizon Europe framework. This initiative seeks to dynamize and accelerate innovation in Life Sciences and Healthtech by fostering interconnectedness among Europe’s innovation ecosystems. Why Attend? This panel discussion is essential for anyone interested in understanding and navigating the European innovation ecosystem, particularly in the healthtech and life sciences sectors. Insights from these thought leaders will shed light on collaborative efforts and strategies that are shaping the future of healthcare and biotechnological innovations. For registration and more information, please visit www.spinoff.bg. Engage with the minds shaping the future of European innovation at SpinOff 2024! #SpinOff2024 #INNAXE4EU #HealthTech #LifeSciences #EuropeanInnovation

I am thrilled to share insights from the recently concluded Global Bio-India 2024, held from September 12-14 at Pragati Maidan, New Delhi. This year's event, organized by the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), brought together a vibrant community of national and international stakeholders in the biotechnology sector. The theme of this year’s event, “Biotech Innovation and Bio-manufacturing,” emphasized India's growing capabilities and potential as a global hub for biotech research and manufacturing. The event featured:Launch of 11 Innovative Products: Indian biotech startups showcased groundbreaking products that underline our country's emerging talent in biosciences. Networking Opportunities: The event facilitated meaningful interactions among industry leaders, researchers, and investors, paving the way for future collaborations. In an era where data is at the core of biotechnology advancements, protecting sensitive information has never been more crucial. Biotech companies handle vast amounts of sensitive data, including patient information and proprietary research. Ensuring robust data protection measures is essential not only for compliance with regulations but also for maintaining trust with stakeholders.The recent discussions at Global Bio-India highlighted the importance of implementing stringent data privacy practices to safeguard intellectual property and patient data. As we innovate, let’s prioritize data security to prevent breaches that could compromise research integrity and patient confidentiality. As we look ahead, initiatives like the #BioE3Policy aim to position India as a global powerhouse in biotechnology, focusing on sustainable development and job creation. Kudos to everyone involved in making this event a success! Let’s continue to drive innovation and explore new horizons in biotechnology together. 💡🔬#GlobalBioIndia2024 #Biotechnology #Innovation #DataProtection #BioManufacturing #IndiaBiotech #Networking #Collaboration #SustainableDevelopment

🚀 Exciting News! #InnoMedCatalyst Project Kick-off Meeting 🚀 We are thrilled to announce the launch of #InnoMedCatalyst, a groundbreaking #European initiative funded by the #I3Programme strand 2b European Innovation Council and SMEs Executive Agency (EISMEA), dedicated to catalyzing the regional innovation capacity of the #MedicNest #Digital #PrecisionMedicine ecosystem and #beyond. This project unites #clusters #MedTech #startups, #scaleups, #investors, #VentureCapitalists and #healthcare #providers to drive the future of #5PMedicine (#Predictive, #Preventive, #Precise, #Personalized, #Participatory). 🗝️ Key Objectives of InnoMedCatalyst: 📊 Mapping regional value chains of 5P digital medicine 🗺️ Creating roadmaps towards a regional innovative ecosystem in 5P Digital Medicine, along with an interregional roadmap to align efforts across the InnoMedCatalyst interconnected ecosystem 🚀 Supporting 36 startups and entrepreneurs in digital health 🌍 Organizing 25+ collaborative activities, including forums, workshops, demo days, and twinning events 🔗 Building an open innovation network for 5P Medicine based on the #LifeSciencesOpenSpace platform supported by Klaster LifeScience Krakow to match innovators, investors, and healthcare providers 💼 Developing an European pipeline of 20+ investment-ready projects in 5P digital medicine by 2026 🗓️ Kick-off Meeting: 📅 October 22-23, 2024 📍 Rubik Hub, Piatra-Neamt, Romania 🚀 This marks the official start of our mission, where #InnoMedCatalyst #consortium led by North-East Regional Development Agency / Agentia pentru Dezvoltare Regionala Nord-Est will lay the groundwork for impactful collaboration of innovation leaders from across Europe: MEDVIA, Hellenic Biocluster (HBio), Imago-Mol Cluster, Clust-ER Health - Emilia-Romagna Biocat, BioRegion of Catalonia, Klaster LifeScience Krakow, Health Cluster Portugal, Health & Life Sciences Cluster Bulgaria - BioCluster.bg, Startup Madeira, Cluster-SIVI, #InPulsePartners, EUREGHA - European Regional and Local Health Authorities 🤝 💡 Stay tuned for updates on the outcomes of this meeting and opportunities to engage with us as we catalyze the change we want to see in the world of precision and personalized medicine and beyond, towards 5P Medicine. 🌐✨ #InnoMedCatalyst #I3Programme #PrecisionMedicine #DigitalHealth #5PMedicine #HealthcareInnovation #MedTech #OpenInnovation #EuropeanInnovation #EISMEA